Citius Pharmaceuticals Inc

Citius Pharmaceuticals Inc a specialty pharmaceutical company engages in the development and commercialization of critical care products focusing on antiinfective products in adjunct cancer care prescription products and mesenchymal stem cell therapy The company is developing five proprietary products comprising MinoLok an antibiotic lock solution to treat patients with catheterrelated bloodstream infections by salvaging the infected catheter MinoWrap a liquifying gelbased wrap for reduction of tissue expander infections following breast reconstructive surgeries HaloLido a corticosteroidlidocaine topical formulation that intends to provide antiinflammatory and anesthetic relief to persons suffering from hemorrhoids NoveCite a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome and IONTAK an engineered IL2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous Tcell lymphoma Citius Pharmaceuticals Inc was founded in 2007 and is headquartered in Cranford New Jersey